Preferred Label : FOLFOX-Cetuximab/Encorafenib Regimen;
NCIt synonyms : FOLFOX/Cetuximab/Encorafenib; FOLFOX/Encorafenib/Cetuximab; Folinic Acid/Fluorouracil/Oxaliplatin/Cetuximab/Encorafenib Regimen; FOLFOX-Encorafenib/Cetuximab; FOLFOX-Cetuximab-Encorafenib; FOLFOX-Encorafenib-Cetuximab; Leucovorin/Fluorouracil/Oxaliplatin/Encorafenib/Cetuximab; Leucovorin/Fluorouracil/Oxaliplatin/Cetuximab/Encorafenib; FOLFOX-Braftovi/Erbitux; Cetuximab/Encorafenib/Fluorouracil/Leucovorin/Oxaliplatin; FOLFOX Plus Erbitux/Braftovi; Encorafenib/Cetuximab Plus FOLFOX; Cetuximab/Encorafenib Plus FOLFOX; FOLFOX Plus Cetuximab/Encorafenib; FOLFOX Plus Encorafenib/Cetuximab; Cetuximab-Encorafenib-FOLFOX; Encorafenib/Cetuximab-FOLFOX;
NCIt definition : A regimen consisting of leucovorin, fluorouracil and oxaliplatin (FOLFOX) plus cetuximab
and encorafenib that is used for the treatment of colorectal cancer.;
Origin ID : C215149;
chemotherapy_regimen_has_component
- concept_is_in_subset
- regimen_has_accepted_use_for_disease
